Medication Errors caused by incorrect data entry into intravenous medication infusion devices are the subject of more adverse event reports to the U.S. Food and Drug Administration than any other medical technology. The Association for the Advancement of Medical Instrumentation did a study for the years 2005 through 2009 and found that more than 56,000 adverse events and 700 deaths were associated with infusion devices
Lung cancer screening in high-risk individuals is now also recommended by the United States Preventive Services Task Force (USPSTF), following other professional organizations that have recommended the same. There had been controversy as to whether or not screening by way of chest x-rays and CT scan provided a true benefit in the fight against this cancer. Based on an article in the Annals of Internal Medicine, annual screening with low-dose CT for people at high risk because of age and smoking history is now the recommended standard. High risk individuals are current and former smokers aged 55 to 80 years of age with a smoking history of 30 pack years or who have smoked in the last 15 years.
Lung cancer screening of all current and former smokers with low-dose CT scanning would result in preventing 12,000 deaths in the United States each year. A study in Cancer reported that, compared with chest x-ray, CT screening would reduce lung cancer mortality by 20%. The total number of potentially avoidable deaths could even be greater. The patients in the study were 55 to 74 years of age and smoked at least one pack a day for 30 years. Even though these patients are at risk for cancer, screening is generally performed by chest x-ray which misses 20% of tumors.